Alivus Life Sciences is an API manufacturer based in India. It holds 272 active US drug master files and 43 valid CEPs. Its GMP standing is certified by US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 30 May 2025 as NAI. Customs aggregates show $58.5M of exports covering 903 molecules to 62 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Mumbai, India | Not on file |
| Bharuch, India | 3007514214 |
| Ankleshwar, India | 3004006229 |
| Solapur, India | 3014026060 |
| Molecule | Regulators | Docs |
|---|---|---|
| Esomeprazole | EDQM, US FDA | 9 |
| Rosuvastatin | EDQM, US FDA | 7 |
| Atovaquone | EDQM, US FDA | 6 |
| Ezetimibe | US FDA | 6 |
| Sitagliptin | US FDA | 6 |
| Aprepitant | EDQM, US FDA | 5 |
| Tadalafil | EDQM, US FDA | 5 |
| Telmisartan | EDQM, US FDA | 5 |
| Terbinafine | EDQM, US FDA | 5 |
| Zolpidem | EDQM, US FDA | 5 |
| Bupropion | US FDA | 4 |
| Desloratadine | EDQM, US FDA | 4 |
| Fluconazole | EDQM, US FDA | 4 |
| Glimepiride | EDQM, US FDA | 4 |
| Linezolid | US FDA | 4 |
| Sucralfate | US FDA | 4 |
| Tafamidis | US FDA | 4 |
| Zonisamide | US FDA | 4 |
| Adapalene | EDQM, US FDA | 3 |
| Amiodarone | EDQM, US FDA | 3 |
| Brivaracetam | EDQM, US FDA | 3 |
| Deferasirox | EDQM, US FDA | 3 |
| Dipyridamole | EDQM, US FDA | 3 |
| Fingolimod | EDQM, US FDA | 3 |
| Lacosamide | EDQM, US FDA | 3 |
| Mirabegron | EDQM, US FDA | 3 |
| Perindopril | SFDA (Saudi Arabia), US FDA | 3 |
| Pirfenidone | EDQM, US FDA | 3 |
| Rivaroxaban | EDQM, US FDA | 3 |
| Rizatriptan | EDQM, US FDA | 3 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 2 | None |
| US FDA | None | 2 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $10.7M | 50 |
| 2025 | Not reported | $58.5M | 62 |
| 2021 | $255.0M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Alivus Life Sciences comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.